Interim report 2018-01-01 – 2018-09-30
The Board and Chief Executive Officer of Cereno Scientific AB herewith present the interim report for the third quarter 2018.Summary of the interim report Nine months (2018-01-01 – 2018-09-30) · Net sales were 0 SEK (0 SEK). · Loss after financial items was -7 777 300 SEK (-3 040 934). · Loss per share was -0,60 SEK (-0,28 SEK) before dilution and -0,47 SEK* (-0,28 SEK) after dilution. · Equity ratio was 71,7 % (90,1 %). Three months (2018-07-01 – 2018-09-30) · Net sales were 0 SEK (0 SEK). · Loss after financial items was -2 868 304 SEK (-1 182 976 SEK). ·